Crossmark

Resting-State Gamma-Band Activity at Clinical High Risk for Schizophrenia: Correlation with Clinical Measures and Levels of GABA and Glutamate in Frontal Lobes

Crossref DOI link: https://doi.org/10.1134/S0362119725700410

Published Online: 2025-08-05

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lebedeva, I. S.

Tomyshev, A. S.

Omelchenko, M. A.

Ublinskii, M. V.

Akhadov, T. A.

Kaleda, V. G.
License Information

Text and Data Mining valid from 2025-06-01

Version of Record valid from 2025-06-01
More Information

Article History

Received: 5 September 2024

Revised: 23 December 2024

Accepted: 16 January 2025

First Online: 5 August 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: All studies were conducted in accordance with the principles of biomedical ethics as outlined in the 1964 Declaration of Helsinki and its later amendments. They were also approved by the Ethics Committee of Mental Health Research Center (Moscow), protocol No. 746 dated March 18, 2021.Each participant in the study or their legal representative (parent) provided a voluntary written informed consent after receiving an explanation of the potential risks and benefits, as well as the nature of the upcoming study and the right to withdraw from study with no explanation of reasons.

: The authors of this work declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below